Ligand-binding Assay Validation
Ligand-Binding Assay Validation is the systematic process of confirming that a ligand-binding assay, which quantifies analytes through specific molecular interactions such as antigen-antibody binding, performs with established accuracy, precision, sensitivity, and reliability for its intended bioanalytical use.
205
Publications
12.5K
Citations
1.3K
Authors
380
Institutions
Publications per year
2017–2026
30
205
C.T. Viswanathan, Surendra K. Bansal, Brian Booth et al. · The AAPS Journal · 2007 · 483 citations · Full text
1–5 of 205
1.3K
4
h-index
4
h-index
4
h-index
4
h-index
4
h-index
1–5 of 1.3K
380
Pfizer (United States)
New York, United States
12 h-index
50 publications
1.5K citations
Bristol-Myers Squibb (United States)
New York, United States
11 h-index
66 publications
3.8K citations
Amgen (United States)
Thousand Oaks, United States
8 h-index
15 publications
2.3K citations
Eli Lilly (United States)
Indianapolis, United States
6 h-index
20 publications
2K citations
University Hospital of Basel
Basel, Switzerland
5 h-index
5 publications
370 citations

Biogen (United States)
Cambridge, United States
5 h-index
5 publications
135 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
5 h-index
33 publications
18.9K citations
United States Military Academy
West Point, United States
5 h-index
17 publications
731 citations
1–8 of 380
BIO · 25 publications · 615 citations
14
h-index
12 publications · 633 citations
12
h-index
11 publications · 964 citations
11
h-index
AAPSJ · 10 publications · 722 citations
10
h-index
JCEM · 7 publications · 608 citations
7
h-index
1–5